Ladone Mary Kay
SEC-identified person · CIK 1760737 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Inogen Inc INGN | Director | filed 2022–2026 |
| Bioventus Inc. BVS | Director | filed 2021–2026 |
| Novanta INC NOVT | Director | filed 2024–2026 |
| Kestra Medical Technologies, LTD. KMTS | Director | filed 2025–2025 |
| Hill-Rom Holdings, Inc. hrc | SVP, Corp. Dev., Strat. & IR | filed 2018–2021 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.